GreenHy2 Ltd
(ASX:H2G) Share Price and News

Introduction to GreenHy2 (ASX:H2G)

GreenHy2 (ASX:H2G) is a provider of Solid-State Hydrogen Storage (SSHS) batteries. The technology leverages metal hydrides for hydrogen storage, storing the hydrogen molecules directly in a ferrous titanium lattice.

It is the only provider of this kind of technology resolving the issue of energy storage in a way that is environmentally-friendly (by not relying on fossil-fuel-backed diesel generators) and safe.

The eight key benefits are: Environmental sustainability, exceptional density, ability to operate at an extremely low pressure, an extended lifespan and reliability, the ability to store power indefinitely, reduced safety concerns, versatility and uniqueness.

GreenHy2's History

The company was incepted in 2011 by Charlie Bontempo. It was formerly known as Tempo Australia, only changing its name in 2022. The technology owned by the company was developed in Germany with GKN. H2G and GKN have the exclusive right to integrate, assembly and supply the equipment in Australia and New Zealand, as well as the right to act on a non-exclusive basis throughout Southeast Asia on a project-by-project basis subject to GKN's approval.

Future Outlook of GreenHy2

GreenHy2 is at an early stage but has a handful of key partnerships with industry players. In particular, it has run a 12-month trial with Essential Energy to use its hydrogen-powered batteries to power a heritage accommodation cottage on the NSW North Coast.

Is GreenHy2 Ltd (ASX:H2G) a Good Stock to Buy?

Investing in GreenHy2 presents a futuristic opportunity, albeit with risks typical of an early-stage company in an early-stage sector like Hydrogen. Overall, there's too much risk for most investors (particularly retail investors) to consider it.

Our Stock Analysis

how to value resources stocks?

How to value resources stocks? Here are 3 unique multiples investors can use

The question of how to value resources stocks on the ASX is not an easy one to answer, because there…

Alterity Therapeutics

Alterity Therapeutics (ASX:ATH) more than doubled after its Phase 2 results, but its still only $80m

Alterity Therapeutics (ASX:ATH) hit the jackpot last week. Any clinical-stage biotech achieving a positive Phase 2 outcome is good news,…

Trump’s Stargate Project

Trump’s Stargate Project & DeepSeek: The Next AI Arms Race?

The global spotlight is on AI following rapid development in the sector, and nations are engaged in a fierce battle…

struggling ASX retail stocks

5 struggling ASX retail stocks to avoid for the time being

5 struggling ASX retail stocks to avoid! Autosports Group (ASX:ASG) The wealthy have been less affected by the cost of…

will Star Entertainment stay afloat

How much longer will Star Entertainment stay afloat? How big of a reprieve will the $60m fire sale of its events centre be?

How much longer will Star Entertainment stay afloat? By now it seems a fait accompli that Star Entertainment (ASX:SGR) will…

dgl group

DGL Group (ASX:DGL): Will 2025 be better for DGL and its investors?

Poor DGL Group (ASX:DGL). It was a company that ran hard for several months in 2021, but has substantially retreated…

Frequently Asked Questions

GreenHy2 specializes in developing Solid State Hydrogen Storage Batteries integrated with 100% renewable energy generation.